Bacterial Vaginosis and Trichomoniasis Treatment Guidelines

Introduction to Treatment

The Centers for Disease Control and Prevention recommends treating nonpregnant women with bacterial vaginosis using metronidazole 500 mg orally twice daily for 7 days, achieving cure rates of 78-84% 1, 2

For nonpregnant women, the first-line oral therapy is metronidazole 500 mg orally twice daily for 7 days, with cure rates of 78-84% 1, 2
Alternative regimens for nonpregnant women include clindamycin cream 2% intravaginally at bedtime for 7 days, with a cure rate of 82% 1, and metronidazole gel 0.75% intravaginally twice daily for 5 days, with a cure rate of 75% 1
The American College of Obstetricians and Gynecologists recommends that pregnant women use metronidazole 250 mg orally three times daily for 7 days to minimize fetal exposure while providing systemic coverage for possible subclinical upper tract infection 3, 2

The Centers for Disease Control and Prevention recommends treating trichomoniasis with metronidazole 2 g orally as a single dose, achieving cure rates of 90-95% 4, 5
Alternative regimens for trichomoniasis include metronidazole 500 mg orally twice daily for 7 days, with a cure rate of 89% 4, 5

The American College of Obstetricians and Gynecologists recommends that metronidazole is contraindicated in the first trimester of pregnancy, but after the first trimester, pregnant women can be treated with metronidazole 2 g orally as a single dose 4
For HIV-infected patients, the same treatment regimens as HIV-negative patients can be used 2, 4, 5

The Centers for Disease Control and Prevention recommends that routine follow-up is unnecessary for patients who become asymptomatic after treatment, but if symptoms persist, re-evaluation for treatment failure or reinfection is necessary 4
For trichomoniasis, partner treatment is mandatory, and all sexual partners must be treated simultaneously with the same dose to prevent reinfection 4, 5